Correlation Between Caribou Biosciences and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Caribou Biosciences and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Pasithea Therapeutics.
Diversification Opportunities for Caribou Biosciences and Pasithea Therapeutics
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Caribou and Pasithea is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Pasithea Therapeutics
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Pasithea Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 37.73 times less risky than Pasithea Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Pasithea Therapeutics Corp is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 1.00 in Pasithea Therapeutics Corp on October 14, 2024 and sell it today you would earn a total of 2.46 from holding Pasithea Therapeutics Corp or generate 246.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 50.0% |
| Values | Daily Returns |
Caribou Biosciences vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Caribou Biosciences |
| Pasithea Therapeutics |
Caribou Biosciences and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Caribou Biosciences and Pasithea Therapeutics
The main advantage of trading using opposite Caribou Biosciences and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |